Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
April 1, 2021 CLOV A 38,392 · · 38,392 Direct · Acquired (price as of 2026-10-05)
Jan. 7, 2021 CLOV A 1,324,728 · · 1,324,728 Indirect · Acquired (price as of 2026-10-05)
Jan. 7, 2021 CLOV A 2,565,954 · · 2,565,954 Indirect · Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
April 1, 2021 CLOV Restricted Stock Unit Class A Common Stock (38,392) · · 38,392 Acquired
Jan. 7, 2021 CLOV Class B Common Stock Class A Common Stock (1,324,728) · · 1,324,728 Acquired
Jan. 7, 2021 CLOV Class B Common Stock Class A Common Stock (2,565,954) · · 2,565,954 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).